Tag: Kyowa Hakko Kirin

Kyowa Kirin Announces FDA Acceptance of Istradefylline (KW-6002) New Drug Application Resubmission in the US

April 4, 2019 Off

Kyowa Kirin Announces FDA Acceptance of Istradefylline (KW-6002) New Drug Application Resubmission in the US

By BusinessWire

TOKYO–(BUSINESS WIRE)–Kyowa Hakko Kirin Co., Ltd. (TOKYO:4151, President and CEO: Masashi Miyamoto, “Kyowa Kirin”) announced that the U.S. Food and…

GSK, Kyowa Hakko Kirin mutual work on potential oral treatment for CKD related anaemia

November 22, 2018 Off

GSK, Kyowa Hakko Kirin mutual work on potential oral treatment for CKD related anaemia

By Dino Mustafić

GSK and Kyowa Hakko Kirin will together commercialize in Japan the treatment of chronic kidney disease related anaemina, which GKS…